Warning letter
Bakkavor Foods USA Inc.: warning letter of Aug 8, 2022
FDA warning letter 630545 · Office of Human and Animal Food Operations – East Division 3
Key facts
| Reference number | 630545 |
|---|---|
| Company | Bakkavor Foods USA Inc. |
| Subject | CGMP/Food/Prepared, Packed or Held Under Insanitary Conditions/Adulterated/L. monocytogenes |
| Issue date | Aug 8, 2022 |
| Posted date | Nov 1, 2022 |
| Issuing office | Office of Human and Animal Food Operations – East Division 3 |
| Product type | Food/Cosmetics |
| CFR sections cited | 123.11, 117, 123, 123.3, 123.6, 123.8, 117.20(b)(4), 117.35(a), 117.35(e), 117.40(a)(1), 117.80(c)(2), 117.130(a)(1) and 4 more |
| Inspection city | Charlotte |
| Inspection ZIP | 28273 |
| Inspection start date | Feb 7, 2022 |
| Letter on fda.gov | fda.gov |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: